{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Maple Grove",
      "state": "MN",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64085",
      "recalling_firm": "Upsher Smith Laboratories, Inc.",
      "address_1": "6701 Evenstad Drive",
      "address_2": "N/A",
      "postal_code": "55369",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-127-2013",
      "product_description": "Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.",
      "product_quantity": "11,316 bottles",
      "reason_for_recall": "Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.",
      "recall_initiation_date": "20121210",
      "center_classification_date": "20130116",
      "termination_date": "20131119",
      "report_date": "20130123",
      "code_info": "Lot #: 310162, Exp 09/14"
    }
  ]
}